Cutera, Inc. (CUTR) EVP Sells $62,434.68 in Stock

Cutera, Inc. (NASDAQ:CUTR) EVP Larry Laber sold 2,563 shares of the company’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $24.36, for a total value of $62,434.68. Following the transaction, the executive vice president now directly owns 74,203 shares in the company, valued at approximately $1,807,585.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Larry Laber also recently made the following trade(s):

  • On Thursday, June 1st, Larry Laber sold 957 shares of Cutera stock. The shares were sold at an average price of $22.95, for a total value of $21,963.15.
  • On Thursday, May 25th, Larry Laber sold 6,482 shares of Cutera stock. The shares were sold at an average price of $22.89, for a total value of $148,372.98.
  • On Monday, April 24th, Larry Laber sold 6,824 shares of Cutera stock. The shares were sold at an average price of $20.66, for a total value of $140,983.84.
  • On Wednesday, April 19th, Larry Laber sold 2,176 shares of Cutera stock. The shares were sold at an average price of $20.54, for a total value of $44,695.04.

Cutera, Inc. (NASDAQ:CUTR) traded up 1.53% during trading on Friday, reaching $23.30. The company’s stock had a trading volume of 100,668 shares. The firm has a 50 day moving average price of $21.57 and a 200-day moving average price of $19.76. The stock has a market cap of $322.89 million, a price-to-earnings ratio of 89.27 and a beta of 0.62. Cutera, Inc. has a 52-week low of $10.42 and a 52-week high of $24.78.

Cutera (NASDAQ:CUTR) last announced its earnings results on Monday, May 1st. The medical device company reported ($0.07) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.07). The firm had revenue of $29.30 million for the quarter, compared to the consensus estimate of $29 million. Cutera had a return on equity of 9.21% and a net margin of 2.89%. The business’s quarterly revenue was up 30.8% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.16) EPS. On average, analysts expect that Cutera, Inc. will post $0.47 earnings per share for the current year.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

TRADEMARK VIOLATION NOTICE: “Cutera, Inc. (CUTR) EVP Sells $62,434.68 in Stock” was published by sleekmoney and is the property of of sleekmoney. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://sleekmoney.com/cutera-inc-cutr-evp-sells-62434-68-in-stock/1915910.html.

Several equities analysts have recently issued reports on the company. Sidoti assumed coverage on Cutera in a research note on Tuesday, April 11th. They set a “buy” rating and a $27.00 price target on the stock. Zacks Investment Research lowered Cutera from a “hold” rating to a “sell” rating in a research note on Thursday, May 4th. Finally, TheStreet lowered Cutera from a “b-” rating to a “c” rating in a research note on Monday, May 1st.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Teachers Advisors LLC increased its position in shares of Cutera by 56.0% in the fourth quarter. Teachers Advisors LLC now owns 38,794 shares of the medical device company’s stock valued at $673,000 after buying an additional 13,923 shares during the last quarter. Oberweis Asset Management Inc. bought a new position in shares of Cutera during the fourth quarter valued at approximately $376,000. Perritt Capital Management Inc. increased its position in shares of Cutera by 25.6% in the fourth quarter. Perritt Capital Management Inc. now owns 50,000 shares of the medical device company’s stock valued at $868,000 after buying an additional 10,200 shares during the last quarter. Two Sigma Investments LP increased its position in shares of Cutera by 16.4% in the fourth quarter. Two Sigma Investments LP now owns 53,498 shares of the medical device company’s stock valued at $928,000 after buying an additional 7,519 shares during the last quarter. Finally, Menta Capital LLC increased its position in shares of Cutera by 21.9% in the fourth quarter. Menta Capital LLC now owns 102,695 shares of the medical device company’s stock valued at $1,782,000 after buying an additional 18,469 shares during the last quarter. 81.82% of the stock is currently owned by hedge funds and other institutional investors.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/cutera-inc-cutr-evp-sells-62434-68-in-stock/1915910.html

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *